1. Home
  2. TARS vs BBUC Comparison

TARS vs BBUC Comparison

Compare TARS & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • BBUC
  • Stock Information
  • Founded
  • TARS 2016
  • BBUC 2022
  • Country
  • TARS United States
  • BBUC United States
  • Employees
  • TARS N/A
  • BBUC N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • BBUC
  • Sector
  • TARS Health Care
  • BBUC
  • Exchange
  • TARS Nasdaq
  • BBUC Nasdaq
  • Market Cap
  • TARS 1.8B
  • BBUC 1.9B
  • IPO Year
  • TARS 2020
  • BBUC N/A
  • Fundamental
  • Price
  • TARS $53.26
  • BBUC $24.89
  • Analyst Decision
  • TARS Strong Buy
  • BBUC
  • Analyst Count
  • TARS 5
  • BBUC 0
  • Target Price
  • TARS $54.20
  • BBUC N/A
  • AVG Volume (30 Days)
  • TARS 469.2K
  • BBUC 36.7K
  • Earning Date
  • TARS 11-13-2024
  • BBUC 01-01-0001
  • Dividend Yield
  • TARS N/A
  • BBUC 1.00%
  • EPS Growth
  • TARS N/A
  • BBUC N/A
  • EPS
  • TARS N/A
  • BBUC N/A
  • Revenue
  • TARS $129,621,000.00
  • BBUC $7,945,000,000.00
  • Revenue This Year
  • TARS $895.24
  • BBUC N/A
  • Revenue Next Year
  • TARS $73.78
  • BBUC N/A
  • P/E Ratio
  • TARS N/A
  • BBUC N/A
  • Revenue Growth
  • TARS 801.96
  • BBUC 56.83
  • 52 Week Low
  • TARS $18.84
  • BBUC $18.21
  • 52 Week High
  • TARS $54.44
  • BBUC $28.29
  • Technical
  • Relative Strength Index (RSI)
  • TARS 64.67
  • BBUC 35.73
  • Support Level
  • TARS $48.45
  • BBUC $25.37
  • Resistance Level
  • TARS $53.85
  • BBUC $25.97
  • Average True Range (ATR)
  • TARS 2.40
  • BBUC 0.65
  • MACD
  • TARS -0.14
  • BBUC -0.31
  • Stochastic Oscillator
  • TARS 80.30
  • BBUC 0.73

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a global basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.

Share on Social Networks: